These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35476174)

  • 1. Interactions between nuclear receptors glucocorticoid receptor α and peroxisome proliferator-activated receptor α form a negative feedback loop.
    Gao H; Li Y; Chen X
    Rev Endocr Metab Disord; 2022 Oct; 23(5):893-903. PubMed ID: 35476174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB.
    Bougarne N; Paumelle R; Caron S; Hennuyer N; Mansouri R; Gervois P; Staels B; Haegeman G; De Bosscher K
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7397-402. PubMed ID: 19376972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.
    Marino JS; Stechschulte LA; Stec DE; Nestor-Kalinoski A; Coleman S; Hinds TD
    J Biol Chem; 2016 Dec; 291(50):25776-25788. PubMed ID: 27784782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms Underlying the Functional Cooperation Between PPARα and GRα to Attenuate Inflammatory Responses.
    Bougarne N; Mylka V; Ratman D; Beck IM; Thommis J; De Cauwer L; Tavernier J; Staels B; Libert C; De Bosscher K
    Front Immunol; 2019; 10():1769. PubMed ID: 31447832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.
    Hermanowski-Vosatka A; Gerhold D; Mundt SS; Loving VA; Lu M; Chen Y; Elbrecht A; Wu M; Doebber T; Kelly L; Milot D; Guo Q; Wang PR; Ippolito M; Chao YS; Wright SD; Thieringer R
    Biochem Biophys Res Commun; 2000 Dec; 279(2):330-6. PubMed ID: 11118287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive influences of peroxisome proliferator-activated receptor alpha activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat.
    Holness MJ; Smith ND; Greenwood GK; Sugden MC
    Diabetologia; 2005 Oct; 48(10):2062-8. PubMed ID: 16132960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal.
    Lee HY; Gao X; Barrasa MI; Li H; Elmes RR; Peters LL; Lodish HF
    Nature; 2015 Jun; 522(7557):474-7. PubMed ID: 25970251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats.
    Chen X; Li M; Sun W; Bi Y; Cai M; Liang H; Yu Q; He X; Weng J
    Biochem Biophys Res Commun; 2008 Apr; 368(4):865-70. PubMed ID: 18267115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance?
    Whorwood CB; Donovan SJ; Wood PJ; Phillips DI
    J Clin Endocrinol Metab; 2001 May; 86(5):2296-308. PubMed ID: 11344242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agonist-induced down-regulation of hepatic glucocorticoid receptor via peroxisome proliferator-activated receptor in SD rats].
    Chen X; Li M; Sun WP; Bi Y; Cai MY; Liang H; Yu QQ; He XY; Weng JP
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3276-9. PubMed ID: 20193367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies.
    Téblick A; Van Dyck L; Van Aerde N; Van der Perre S; Pauwels L; Derese I; Debaveye Y; Wouters PJ; Vanhorebeek I; Langouche L; Van den Berghe G
    EBioMedicine; 2022 Jun; 80():104057. PubMed ID: 35584557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α.
    Kim KH; Moore DD
    Dig Dis; 2017; 35(3):203-209. PubMed ID: 28249296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
    Sugden MC; Holness MJ
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):891-900. PubMed ID: 18793157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.
    Frey FJ; Odermatt A; Frey BM
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):451-8. PubMed ID: 15199296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance.
    Gross KL; Oakley RH; Scoltock AB; Jewell CM; Cidlowski JA
    Mol Endocrinol; 2011 Jul; 25(7):1087-99. PubMed ID: 21527497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hop bitter acids efficiently block inflammation independent of GRalpha, PPARalpha, or PPARgamma.
    Van Cleemput M; Heyerick A; Libert C; Swerts K; Philippé J; De Keukeleire D; Haegeman G; De Bosscher K
    Mol Nutr Food Res; 2009 Sep; 53(9):1143-55. PubMed ID: 19655312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
    Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
    Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.